PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Combined ethinylestradiol 20mcg
Presentation Product Chemical substance Chapter Items dispensed
Ethinylest 33.9microg/Norelgestromin 203microg/24hours ptch
0703010E0AAAEAE
Combined ethinylestradiol 20mcg Combined ethinylestradiol 20mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 7,202
Ethinylestradiol 20microgram / Desogestrel 150microgram tab
0703010E0AAABAB
Combined ethinylestradiol 20mcg Combined ethinylestradiol 20mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 5,107
Ethinylestradiol 20microgram / Gestodene 75microgram tablets
0703010E0AAACAC
Combined ethinylestradiol 20mcg Combined ethinylestradiol 20mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 2,881
Ethinylestradiol 20microgram / Drospirenone 3mg tablets
0703010E0AAAFAF
Combined ethinylestradiol 20mcg Combined ethinylestradiol 20mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 1,812
Ethinylestradiol 20microg / Norethisterone acetate 1mg tab
0703010E0AAAAAA
Combined ethinylestradiol 20mcg Combined ethinylestradiol 20mcg Obstetrics, Gynaecology and Urinary-Tract Disorders 4

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.